Dr. Michael Nessim Youssef, MD

Dr. Youssef practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Youssef's NPI, 1790102028, was assigned on March 25, 2014. Dr. Youssef graduated from Medical University of South Carolina College of Medicine in 2014. Dr. Youssef holds Texas license S1024.

Dr. Youssef's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Youssef's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Youssef is also affiliated with Parkland Memorial Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Youssef to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Youssef practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Youssef's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Youssef's licenses on file in 3 states: Texas, Georgia and Pennsylvania.

Dmand AI lists cerebrovascular disease, epilepsy, hereditary polyneuropathy and neuropathy among the conditions Dr. Youssef treats.

CMS data shows 496 Medicare services from Dr. Youssef across 5 procedure codes in 2024, for 133 Medicare patients. Medicare paid $32,134 for them.

CMS counts 133 Medicare patients who saw Dr. Youssef in 2024. The largest group is 65 to 74, with 68 patients. 71% of them have high cholesterol, and 70% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Youssef's median patient age at 53, with 53% women.

In 2024, Dr. Youssef wrote 774 Medicare Part D claims for 123 patients. 90% of them were for generic drugs. CMS names the drug for 547 of them, across 19 drugs with 11 or more claims each, at $641,365 in total drug cost. In 2023, CMS named 578 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Youssef for performance year 2024, reported as part of a group. Dr. Youssef accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Youssef as offering telehealth.

Dmand AI links 42 papers to Dr. Youssef, published from 2009 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Brain Neoplasms, Glioblastoma and Composite Resins. Dr. Youssef has published most often in Cancer Lett. Dr. Youssef's most frequent co-authors are Jacob Joseph Mandel, MD, Akash J. Patel, MD and John F. De Groot, MD.

Dmand AI links Dr. Youssef to 5 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Astrocytoma, Brain Neoplasms and Carcinoma, Non-Small-Cell Lung. Alliance for Clinical Trials in Oncology sponsors the most, 2. Open Payments lists research payments to Dr. Youssef that name 1 trial.

CMS Open Payments shows 45 general payments to Dr. Youssef from 15 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 63% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $1,341. It also lists 1 research payment totaling $6,650 in 2021, naming 1 clinical trial.

Dr. Youssef graduated from Medical University of South Carolina College of Medicine in 2014.

Dr. Youssef is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.